IMMURON (IMRN) vs NKGen Biotech, Inc. (NKGN)

IMMURON and NKGen Biotech, Inc. are both Biotechnology companies. IMMURON and NKGen Biotech, Inc. are of similar size ($9.6M and $8.8M). NKGen Biotech, Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, NKGen Biotech, Inc. leads on 5 and IMMURON on 4.

Valuation

Metric IMRN NKGN Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.93 n/m 0.74
EV/Sales (3.50) n/m 10.73
Earnings yield (1.75%) (10,600.00%) (28.84%)
Free cash flow yield 0.00% (4,296.38%) (23.03%)

Profitability

Metric IMRN NKGN Biotechnology median
Gross margin 71.28% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (262.71%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 44.70% (57.72%)
Return on assets 0.00% (146.49%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMRN NKGN Biotechnology median
Revenue growth (TTM) (6.62%) — 5.64%
EPS growth (last fiscal year) 37.29% 71.38% —
Revenue growth, 5-year CAGR 116.96% — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMRN NKGN Biotechnology median
Debt to equity 0.00 (0.59) 0.00
Current ratio 7.17 0.05 4.73
Net debt to EBITDA 2.25 (1.69) 0.96

Dividend

Metric IMRN NKGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric IMRN NKGN Biotechnology median
Market cap 9.60m 8.76m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack